February 11, 2026- Mayo Clinic announced additional capabilities within Mayo Clinic Platform_Orchestrate that make it more efficient for researchers to access standardized, real-world cancer data from Mayo Clinic and participating Mayo Clinic Platform_Connect partners. This gives researchers the ability to generate insights that can accelerate cancer research and improve patient care.
Developing new cancer therapies is a long and complex process that typically takes many years. Orchestrate’s capabilities can help shorten this timeline by giving researchers faster access to high-quality, real-world cancer data.
Orchestrate is now using an industry-leading, standardized framework to organize complex cancer information, known as Observational Medical Outcomes Partnership (OMOP) Oncology. The new function can present de-identified data in a consistent, structured and research-ready format. This includes standardized information such as tumor characteristics, biomarkers, staging, treatments, progression and outcomes. These key oncology attributes are refined from a rich background of structured data (e.g., diagnoses, lab test results) and unstructured data (e.g., imaging, pathology and radiology reports) already integrated on Mayo Clinic Platform to enable better clinical insights and research.